Lupin recalls over 24000 bottles of Fluocinolone Acetonide topical solution from US

Published On 2019-02-04 04:15 GMT   |   Update On 2019-02-04 04:15 GMT

New Delhi: Mumbai based drug firm Lupin is recalling from the US and Puerto Rico over 24 thousand bottles of Fluocinolone Acetonide topical solution used for the treatment of a variety of skin conditions.


According to a USFDA report, Lupin Somerset is recalling 24,180 bottles of Fluocinolone Acetonide topical solution USP, 0.01 per cent in 60 ml bottle, manufactured by Novel Laboratories Inc for US-based Lupin Pharmaceuticals Inc.


Read Also: Lupin gets 6 observations from USFDA for its Pithampur Unit-2


The reason for the recall is failed impurities/degradation specifications, it added.


The distribution pattern of the product was nationwide in the US and Puerto Rico, the report said.


The voluntary ongoing recall is a class II recall, it added.


According to USFDA, a class II recall is initiated in a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.


Fluocinolone Acetonide topical solution is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.


Read Also: Lupin recalls over 23,000 bottles of Nitrofurantoin oral suspension in US

Article Source : With input

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News